Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Lung Disease (ILD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03562416
What this trial is testing

Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects

Who this might be right for
Idiopathic Pulmonary FibrosisLung Transplant; Complications
Temple University 1
Not applicableActive Not RecruitingNCT05914506
What this trial is testing

Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease
University of Aarhus 30
Not applicableStudy completedNCT01762449
What this trial is testing

Morbidity and Mortality Follow Up for the Scleroderma Lung Study

Who this might be right for
Scleroderma
Duke University 158
Very early researchStudy completedNCT03928847
What this trial is testing

Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hal Chapman 35
Not applicableLooking for participantsNCT07723872
What this trial is testing

Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease

Who this might be right for
Interstitial Lung Disease (ILD)Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis+2 more
Hospital de Granollers 100
Not applicableUnknownNCT03840928
What this trial is testing

PatientSpot Formerly Known as ArthritisPower

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisFibromyalgia+61 more
Global Healthy Living Foundation 40,000
Not applicableLooking for participantsNCT07406932
What this trial is testing

A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome

Who this might be right for
Antisynthetase SyndromeInterstitial Lung Disease (ILD)
China-Japan Friendship Hospital 80
Not applicableStudy completedNCT01121367
What this trial is testing

Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema

Who this might be right for
Pulmonary FibrosisEmphysema
Beijing Chao Yang Hospital 82
Not applicableLooking for participantsNCT05567133
What this trial is testing

Risk Indicators of Sarcoidosis Evolution-Unified Protocol

Who this might be right for
Sarcoidosis, Pulmonary
University of California, San Francisco 200
Not applicableEnrolling By InvitationNCT06746077
What this trial is testing

Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children.

Who this might be right for
Lung Diseases
Aarhus University Hospital 200
Not applicableUnknownNCT02006134
What this trial is testing

Pediatric Vasculitis Initiative

Who this might be right for
Wegeners Granulomatosis (Granulomatosis With Polyangiitis)Microscopic PolyangiitisEosinophilic Granulomatosis With Polyangiitis+4 more
University of British Columbia 1,600
Not applicableStudy completedNCT03800914
What this trial is testing

High Intensity Interval Training in Fibrotic Interstitial Lung Disease

Who this might be right for
Fibrotic Interstitial Lung Disease
Monash University 131
Not applicableStudy completedNCT03958071
What this trial is testing

A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 13,264
Testing effectiveness (Phase 2)Looking for participantsNCT07022834
What this trial is testing

Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children

Who this might be right for
Langerhans Cell Histiocytosis (LCH)
West China Second University Hospital 20
Not applicableStudy completedNCT03981406
What this trial is testing

Palliative Care and Quality of Life in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisDepressionAnxiety+3 more
University of Minnesota 22
Not applicableEnded earlyNCT03901534
What this trial is testing

Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD

Who this might be right for
Interstitial Lung DiseaseObstructive Sleep Apnea
Columbia University 2,021
Not applicableStudy completedNCT04564664
What this trial is testing

High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Parc de Salut Mar 10
Early research (Phase 1)Study completedNCT06135363
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 45
Testing effectiveness (Phase 2)Ended earlyNCT03287414
What this trial is testing

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)UnknownNCT05424887
What this trial is testing

Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. 105
Next Page